Corcept Therapeutics Inc. share price logo

Corcept Therapeutics Inc.

NASDAQ: CORT

Mid Cap

$79.69

-0.22

(-0.27%)

as on

Corcept Therapeutics Inc. Stock Performance

as on June 23, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $77.38
    $82.00
    downward going graph

    2.90%

    Downside

    2.90%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $28.66
    $91.00
    downward going graph

    64.04%

    Downside

    14.19%

    Upside

    downward going graph

Corcept Therapeutics Inc. share price movements today

Previous Close
$79.91
Open
$80.70
Volume
692.3K
Day's Low - High
$77.38 - $82.00
52 Week Low - High
$28.66 - $91.00

Corcept Therapeutics Inc. Historical Returns

1 Month Return
+ 32.7 %
3 Month Return
+ 130.69 %
1 Year Return
+ 11.95 %
3 Year Return
+ 257.54 %
5 Year Return
+ 263.89 %

Corcept Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Corcept Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.6B

EPS (TTM)

0.4875

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.22%

PE Ratio (TTM)

228.31

Industry PE ratio

-8.931971830985916

PEG Ratio

0.813

EBITDA

-6.9M

Revenue (TTM)

769.1M

Profit Margin

6.16%

Return On Equity TTM

7.17%

Corcept Therapeutics Inc. Stock Valuation

Track how Corcept Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Corcept Therapeutics Inc. in the last 5 years

  • Overview

  • Trends

Lowest (18.61x)

December 31, 2021

Industry (-8.93x)

June 22, 2026

Today (228.31x)

June 22, 2026

Highest (106.83x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 228.31x

Corcept Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corcept Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$8.6B263.89%228.316.16%NA
BUY$37.1B60.79%69.8712.55%NA
BUY$114.6B139.12%26.835.51%NA
BUY$63.9B14.22%14.8829.65%0.59%

Stock Returns calculator for Corcept Therapeutics Inc. Stock including INR - Dollar returns

The Corcept Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Corcept Therapeutics Inc. investment value today

Current value as on today

₹1,22,087

Returns

₹22,087

(+22.09%)

Returns from Corcept Therapeutics Inc. Stock

₹11,642 (+11.64%)

Dollar Impact

₹10,445 (+10.44%)

Analyst Recommendation on Corcept Therapeutics Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Corcept Therapeutics Inc.. Average target price of $88

Corcept Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Corcept Therapeutics Inc..

What analysts predicted

9.44%UPSIDE

Target Price

$88

Current Price

$79.69

Analyzed by

11 Analysts

Target

$88.00

Corcept Therapeutics Inc. target price $88, a slight upside of 9.44% compared to current price of $79.69. According to 11 analysts rating.

Indian Investors' Interest in Corcept Therapeutics Inc. Stock

Search interest for Corcept Therapeutics Inc. Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:20% versus previous 30 day period

Corcept Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
135
146
163
182
181
157
194
207
202
164
Gross Profit
133
144
161
179
178
154
190
203
199
162
Operating Income
31
29
35
46
25
3
26
10
4
-49
EBITDA
32
29
41
47
25
3
32
15
10
-44
Interest Expense
3
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
36
34
41
52
31
9
31
15
9
-44
Income Tax Expense
5
7
6
5
1
-10
-3
-4
-14
-13
Net Income
31
27
35
46
30
20
35
19
24
-31
Net Profit Margin
23.16%
18.91%
21.67%
25.58%
16.71%
13.07%
18.08%
9.47%
12.02%
-18.92%

Corcept Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
81
159
251
306
353
365
401
482
675
761
Gross Profit
79
155
246
300
348
360
396
475
664
748
Operating Income
10
52
89
111
128
124
112
107
136
44
EBITDA
10
52
89
113
130
127
115
125
162
68
Interest Expense
2
0
2
5
5
3
3
-
-
-
Depreciation
-
0
0
2
2
3
2
2
1
1
Income Before Tax
8
52
92
116
131
125
116
124
161
66
Income Tax Expense
-
-76
16
22
25
12
14
18
20
-33
Net Income
8
129
75
94
106
112
101
106
139
99
Net Profit Margin
10.01%
81.11%
30.01%
30.73%
29.96%
30.74%
25.24%
22.00%
20.70%
13.09%

Corcept Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
27
35
46
30
20
35
19
98
-31
Operating Cash Flow
23
41
73
59
5
43
54
38
-16
Investing Cash Flow
-9
-60
-44
-64
-3
70
14
-11
4
Financing Cash Flow
0
-2
-21
-4
-39
-102
-46
-31
0
Change in Cash
14
-21
8
-9
-37
12
22
-4
-11

Corcept Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
129
75
94
106
112
101
106
141
98
Operating Cash Flow
60
115
136
151
167
120
127
198
141
Investing Cash Flow
-73
-90
-117
-119
136
-114
90
-177
69
Financing Cash Flow
-7
-14
-28
12
-302
-17
-148
-28
-220
Change in Cash
-20
10
-10
44
1
-11
69
-7
-7

Global Institutional Holdings in Corcept Therapeutics Inc.

Funds
Holdings
AQR Capital Management LLC
0.83%
Vanguard Group Inc
8.84%
Citadel Advisors Llc
0.8%
Renaissance Technologies Corp
5.29%
Vanguard Portfolio Management, LLC
4.49%

Corcept Therapeutics Inc. News & Key Events

    Insights on Corcept Therapeutics Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, CORT stock has moved up by 32.7%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, CORT has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 7.7%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 24.28M → -31.20M (in $), with an average decrease of 228.5% per quarter

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 3 quarters, 207.63M → 164.90M (in $), with an average decrease of 10.5% per quarter

    About Corcept Therapeutics Inc.

    Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.
    OrganisationCorcept Therapeutics Inc.
    Headquarters101 Redwood Shores Parkway, Redwood City, CA, United States, 94065
    IndustryBiotechnology
    CEODr. Joseph K. Belanoff M.D.
    E-voting on sharesClick here to vote

    Key Management of Corcept Therapeutics Inc.

    Name

    Title

    Mr. Joseph Douglas Lyon

    Chief Technology & Accounting Officer

    Ms. Monica Tellado

    President of Emerging Markets

    Mr. Roberto W. Vieira

    President of Oncology

    Mr. Atabak Mokari

    CFO & Treasurer

    Mr. Gary Charles Robb J.D.

    Chief Business Officer & Secretary

    Dr. William Guyer Pharm.D.

    Chief Development Officer

    Dr. Hazel Hunt Ph.D.

    Chief Scientific Officer

    Ms. Amy Flood

    Chief Human Resources & Communications Officer

    Dr. Joseph K. Belanoff M.D.

    Co-Founder, President, CEO & Director

    Mr. Sean Maduck

    President of Endocrinology

    FAQs

    What is Corcept Therapeutics Inc. share price today?

    Corcept Therapeutics Inc. share price today is $79.69 as on at the close of the market. Corcept Therapeutics Inc. share today touched a day high of $82 and a low of $77.38.

    What is the 52 week high and 52 week low for Corcept Therapeutics Inc. share?

    Corcept Therapeutics Inc. share touched a 52 week high of $91 on and a 52 week low of $28.66 on . Corcept Therapeutics Inc. stock price today i.e. is closed at $79.69,which is 12.43% down from its 52 week high and 178.05% up from its 52 week low.

    What is Corcept Therapeutics Inc.'s market capitalisation today?

    Corcept Therapeutics Inc. market capitalisation is $0.01T as on .

    How to invest in Corcept Therapeutics Inc. Stock (CORT) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Corcept Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corcept Therapeutics Inc. Shares that will get you 0.0188 shares as per Corcept Therapeutics Inc. share price of $79.69 per share as on June 23, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Corcept Therapeutics Inc. Stock (CORT) from India?

    Indian investors can start investing in Corcept Therapeutics Inc. (CORT) shares with as little as ₹94.68 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹946.80 in Corcept Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Corcept Therapeutics Inc. share’s latest price of $79.69 as on June 23, 2026 at 1:29 am IST, you will get 0.1255 shares of Corcept Therapeutics Inc.. Learn more about fractional shares .

    What are the returns that Corcept Therapeutics Inc. has given to Indian investors in the last 5 years?

    Corcept Therapeutics Inc. stock has given 263.89% share price returns and 26.88% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?